Timing of Intervention for Mixed VHD 10.2.1. Intervention for Mixed AS and AR 1. Zilberszac R, Gabriel H, Schemper M, et al. Outcome of combined stenotic and regurgitant aortic valve disease. J Am Coll Cardiol. 2013;61:1489 95. 2. Egbe AC, Luis SA, Padang R, et al. Outcomes in moderate mixed aor- tic valve disease: is it time for a paradigm shift? J Am Coll Cardiol. 2016;67:2321 9. 10.2.2. Intervention for Mixed AS and MR 1. Gillinov AM, Blackstone EH, Cosgrove DM 3rd, et al. Mitral valve repair with aortic valve replacement is superior to double valve replacement. J Thorac Cardiovasc Surg. 2003;125:1372 87. 2. Nombela-Franco L, Ribeiro HB, Urena M, et al. Significant mitral regurgita- tion left untreated at the time of aortic valve replacement: a comprehen- sive review of a frequent entity in the transcatheter aortic valve replace- ment era. J Am Coll Cardiol. 2014;63:2643 58. 3. Kiramijyan S, Koifman E, Asch FM, et al. Impact of functional versus or- ganic baseline mitral regurgitation on short- and long-term outcomes af- ter transcatheter aortic valve replacement. Am J Cardiol. 2016;117:839 46. 4. Chakravarty T, Van Belle E, Jilaihawi H, et al. Meta-analysis of the impact of mitral regurgitation on outcomes after transcatheter aortic valve im- plantation. Am J Cardiol. 2015;115:942 9. 5. Cort s C, Amat-Santos IJ, Nombela-Franco L, et al. Mitral regurgitation af- ter transcatheter aortic valve replacement: prognosis, imaging predictors, and potential management. JACC Cardiovasc Interv. 2016;9:1603 14. 6. Feldman T, Kar S, Elmariah S, et al. Randomized comparison of percutane- ous repair and surgery for mitral regurgitation: 5-year results of EVEREST II. J Am Coll Cardiol. 2015;66:2844 54. 7. Jeong DS, Park PW, Sung K, et al. Long-term clinical impact of functional mitral regurgitation after aortic valve replacement. Ann Thorac Surg. 2011;92:1339 45. 8. 